An international group of experts reviewed the evidence and guidelines on disease- and non-disease- related faltering growth (FG) in healthy term and SGA infants and children under 2 years old in low-, middle- and high-income countries. Using a modified Delphi process, practical agreed statements and areas for research were developed to provide clarity and guidance to general clinicians for the appropriate identification, assessment and management of FG.